| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 290,329 | 301,360 | 309,837 | 287,106 | | Cost of Revenue | 172,077 | 278,475 | 83,072 | (227,425) | | | Gross Profit | 118,252 | 22,885 | 226,765 | 514,531 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 88,320 | (13,508) | 188,126 | 482,689 | | Non Recurring | 2,105 | (94) | 488 | (5,569) | | Others | 19,055 | 18,575 | 18,496 | 17,118 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,772 | 17,912 | 19,655 | 20,293 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 8,772 | 17,912 | 19,655 | 19,919 | | Interest Expense | (85) | 437 | 940 | 584 | | Income Before Tax | 8,857 | 17,475 | 18,715 | 19,335 | | Income Tax Expense | 2,477 | 5,108 | 4,953 | 6,399 | | Minority Interest | 658 | (658) |
-
| (374) | | | | Net Income From Continuing Ops | 7,038 | 11,709 | 13,762 | 12,936 | | | Non-recurring Events | | Discontinued Operations | (17) | (474) | (43) | (7,491) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,021 | 11,235 | 13,719 | 5,445 | | Preferred Stock And Other Adjustments | (813) | 370 | (370) |
-
| | | Net Income Applicable To Common Shares | $6,208 | $11,605 | $13,349 | $5,445 |
|
0.11% Nasdaq 0.00%
Income Statement
